A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum
Clinical trial NCT01965613 · COMPLETED
Trial details
- NCT number
- NCT01965613
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-31
- Primary completion
- 2016-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.